Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment
Giulia Petroni, Aitziber Buqué, Lisa M. Coussens, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 6, pp. 440-462
Closed Access | Times Cited: 98

Showing 51-75 of 98 citing articles:

Application of CRISPR screen in mechanistic studies of tumor development, tumor drug resistance, and tumor immunotherapy
Min Li, Jin Sun, Guohai Shi
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 7
Epigenetic regulation of cancer
Sheila Spada, Lorenzo Galluzzi
International review of cell and molecular biology (2024), pp. xiii-xvii
Closed Access | Times Cited: 2
Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: a magic key
Xi Zhang, Yunchao Zhang, Qiong Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Mechanical destruction using a minimally invasive Ultrasound Needle induces anti-tumor immune responses and synergizes with the anti-PD-L1 blockade
Jiawei Tang, Junhui Tang, Hui Li, et al.
Cancer Letters (2022) Vol. 554, pp. 216009-216009
Closed Access | Times Cited: 11
Nanomaterials augmented bioeffects of ultrasound in cancer immunotherapy
Xinxin Xie, Jinxia Zhang, Yuan Wang, et al.
Materials Today Bio (2023) Vol. 24, pp. 100926-100926
Open Access | Times Cited: 6
Immunological aspects of central neurodegeneration
Mireia Niso‐Santano, José M. Fuentes, Lorenzo Galluzzi
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
T cell proliferation-related subtypes, prognosis model and characterization of tumor microenvironment in head and neck squamous cell carcinoma
Wanjin Jiang, Qi Yang, Xiaonan Yang, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34221-e34221
Open Access | Times Cited: 2
Trial watch: anticancer vaccination with dendritic cells
Francisca Borges, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
Yu‐Mei Tang, Lei Ye, Peng Gao, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Precision and strategic targeting of novel mutation-specific vulnerabilities in acute myeloid leukemia: the semi-centennial of 7 + 3
Shyam A. Patel
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 9, pp. 1503-1513
Open Access | Times Cited: 4
Multifunctional nano-herb based on tumor microenvironment for enhanced tumor therapy of gambogic acid
Fengyun Li, Zerong Pei, Shuting Chen, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 5, pp. 108752-108752
Closed Access | Times Cited: 4
Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells
Mingyue Liu, Qi Dong, Bo Chen, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 8, pp. 1339-1349
Open Access | Times Cited: 4
Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity
Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 1
Targeting the MHC-I endosomal-lysosomal trafficking pathway in cancer: From mechanism to immunotherapy
Di Ye, Shuang Zhou, Xinyu Dai, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189161-189161
Closed Access | Times Cited: 1
Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors
Qin Ding, Youliang Weng, Ying Li, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e009893-e009893
Open Access | Times Cited: 1
Role of PD‐1 in modulating IFN‐γ‐CXCL9/10‐CXCR3 signaling in breast cancer
Lei Hong, Fang Huang, Zexian Hu, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 12
Closed Access | Times Cited: 1
Autophagy-inducing nutritional interventions in experimental and clinical oncology
Sebastian J. Hofer, Guido Kroemer, Oliver Kepp
International review of cell and molecular biology (2022), pp. 125-158
Closed Access | Times Cited: 7
Myeloid-derived suppressor cells: Emerging players in cancer and beyond
Carlos Jiménez‐Cortegana, Lorenzo Galluzzi
International review of cell and molecular biology (2023), pp. xiii-xix
Closed Access | Times Cited: 3
FNBP1 Facilitates Cervical Cancer Cell Survival by the Constitutive Activation of FAK/PI3K/AKT/mTOR Signaling
Jun Zhang, Xin Li, Yunfei Zhou, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1964-1964
Open Access | Times Cited: 3
Applications and advancements of CRISPR-Cas in the treatment of lung cancer
Lei Pan, Yixin Ju, Fenfen Peng, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 3
Immune Modulatory Effects of Molecularly Targeted Therapy and Its Repurposed Usage in Cancer Immunotherapy
Tiancheng Zhang, Chenhao Zhang, Zile Fu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1768-1768
Open Access | Times Cited: 5
HSF1 is involved in immunotherapeutic response through regulating APOJ/STAT3-mediated PD-L1 expression in hepatocellular carcinoma
Hongxia Cheng, Sikai Wang, Aidan Huang, et al.
Cancer Biology & Therapy (2022) Vol. 24, Iss. 1, pp. 1-9
Open Access | Times Cited: 5
Immunologically relevant effects of radiation therapy on the tumor microenvironment
Claudia Galassi, Vanessa Klapp, Silvia C. Formenti, et al.
Essays in Biochemistry (2023) Vol. 67, Iss. 6, pp. 979-989
Open Access | Times Cited: 2
A functional sgRNA-CRISPR screening method for generating murine RET and NTRK1 rearranged oncogenes
Laura Schubert, Anh‐Tuan Le, Trista K. Hinz, et al.
Biology Open (2023) Vol. 12, Iss. 8
Open Access | Times Cited: 2
Dissecting multifunctional roles of forkhead box transcription factor D1 in cancers
Lin Cheng, Haixu Yan, Yang Liu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188986-188986
Closed Access | Times Cited: 2

Scroll to top